EUROPEAN COMMISSION DG Competition

Only the English text is available and authentic.

REGULATION (EC) No 139/2004 MERGER PROCEDURE

Article 6(1)(b) NON-OPPOSITION Date: 05/07/2018

In electronic form on the EUR-Lex website under document number 32018M8937

EUROPEAN COMMISSION

Brussels, 5.7.2018 C(2018) 4436 final

PUBLIC VERSION

To the Notifying Party

Dear Sir or Madam,

1.1. On 8 June 2018, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which the undertaking Advent International Corporation ("Advent", USA) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control over the whole of the undertaking Zentiva group ("Zentiva", Czech Republic) currently controlled by Sanofi SA. (France), by way of purchase of shares.

2. The business activities of the undertakings concerned are:

- for Advent: a global private equity investor, focused on investments in several sectors, namely business and financial services; healthcare; industrial; retail, consumer and leisure; and technology, media and telecom;

- for Zentiva: a pharmaceutical group focused on the development, manufacturing and marketing of generic pharmaceutical products primarily within Europe.

3.3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(c) of

OJ L 24, 29.1.2004, p. 1 (the 'Merger Regulation'). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ('TFEU') has introduced certain changes, such as the replacement of 'Community' by 'Union' and 'common market' by 'internal market'. The terminology of the TFEU will be used throughout this decision. OJ L 1, 3.1.1994, p. 3 (the 'EEA Agreement'). Publication in the Official Journal of the European Union No C 214, 19.6.2018, p. 11.

Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË

Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.

the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004.

4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement.

For the Commission

(Signed) Johannes LAITENBERGER Director-General

OJ C 366, 14.12.2013, p. 5.

2